|MDACC Study No:||2013-0629 (clinicaltrials.gov NCT No: NCT01850004)|
|Title:||Open-Label Single Arm Phase 2 Study Evaluating Dasatinib Therapy Discontinuation In Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML) With Stable Complete Molecular Response (CMR) DASFREE|
|Principal Investigator:||Jorge Cortes|
|Study Description:||The goal of this clinical research study is to learn about the effects of |
stopping dasatinib in patients with CP-CML who have achieved a CMR.